DAVA Endava
Endava earnings company data as of 4:48 AM ET 10/23
Scheduled
2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 10 Nov | EPS | 0.03 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 1 Oct | EPS | 0.06 | — | — |
| Rev | $182.2M | — | — |
Insider trades
Open-market buys and sales by DAVA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- None no planned (10b5-1) sales
No open-market buys or sales on file.
Also filed in the last 12 months, not counted as buying or selling: 8 option exercises and 8 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.